Form 4: Astrana Health Chief Accounting Officer Reports Share Transaction
SEC Form 4 Filing
Astrana Health's Chief Accounting Officer, John Vong, surrendered 134 shares to cover tax obligations related to vesting restricted stock.
Summary
- John Vong, the Chief Accounting Officer of Astrana Health, Inc., filed a Form 4 indicating a transaction involving the company's common stock.
- On November 30, 2024, Mr. Vong surrendered 134 shares of common stock at a price of $43.25 per share.
- This transaction was to cover tax withholding obligations associated with the vesting of restricted stock.
- Following the transaction, Mr. Vong beneficially owns 17,520 shares of Astrana Health common stock.
- This total includes 11,622 shares of restricted stock that will vest over time, and 76 shares acquired through the Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider transaction, and does not indicate any positive or negative sentiment.
Industry Context
Form 4 filings are a standard part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.
Comparison to Industry Standards
- Form 4 filings are a common practice across all publicly listed companies in the US.
- The transaction is typical for executives receiving stock-based compensation, where shares are often surrendered to cover tax obligations upon vesting.
- The vesting schedule of the restricted stock is also a common practice for incentivizing long-term performance.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine tax-related transaction for an executive.
Key Dates
| Date | Description |
|---|---|
| 11/30/2024 | Date of the share transaction where 134 shares were surrendered. |
| 12/03/2024 | Date the Form 4 was signed by Kathy Diep, as Attorney-in-Fact. |
| 07/11/2025 | First vesting date for 942 shares of restricted stock. |
| 05/12/2025 | First vesting date for tranches of 1,134 shares, 1,134 shares, 1,134 shares, 1,134 shares, and 4,439 shares. |
| 11/30/2025 | First vesting date for tranches of 380 shares and 380 shares. |
| 07/11/2026 | Second vesting date for 945 shares of restricted stock. |
Keywords
Form 4, insider trading, share transaction, restricted stock, tax withholding, beneficial ownership, employee stock purchase plan, Astrana Health, ASTH, John Vong
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.